Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
1,366,275
Value
$65.5M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,366,275$65.5M<0.1%−1,370,250−50.1%ReducedHolders
Q1 20262,736,525$100.6M0.1%−4,674,398−63.1%ReducedHolders
Q4 20257,410,923$377.1M0.3%+4,278,889+136.6%AddedHolders
Q3 20253,132,034$173.8M0.1%+2,735,562+690.0%AddedHolders
Q2 2025396,472$27.4M<0.1%−1,321,926−76.9%ReducedHolders
Q1 20251,718,398$119.3M0.1%+1,087,341+172.3%AddedHolders
Q4 2024631,057$54.3M0.1%+219,416+53.3%AddedHolders
Q3 2024411,641$49.0M0.1%−461,465−52.9%ReducedHolders
Q2 2024873,106$124.6M0.1%−95,718−9.9%ReducedHolders
Q1 2024968,824$124.4M0.1%+433,417+81.0%AddedHolders
Q4 2023535,407$55.4M0.1%+207,041+63.1%AddedHolders
Q3 2023328,366$29.9M<0.1%−107,874−24.7%ReducedConverted for a 2-for-1 splitHolders
Q2 2023218,120$35.3M<0.1%−11,875−5.2%ReducedHolders
Q1 2023229,995$36.6M<0.1%−175,803−43.3%ReducedHolders
Q4 2022405,798$54.9M0.1%+102,333+33.7%AddedHolders
Q3 2022303,465$30.2M<0.1%−140,737−31.7%ReducedHolders
Q2 2022444,202$49.5M0.1%+387,523+683.7%AddedHolders
Q1 202256,679$6.29M<0.1%+10,705+23.3%AddedHolders
Q4 202145,974$5.15M<0.1%−312,213−87.2%ReducedHolders
Q3 2021358,187$34.4M<0.1%+135,708+61.0%AddedHolders
Q2 2021222,479$18.6M<0.1%−4,485−2.0%ReducedHolders
Q1 2021226,964$15.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.